Target Name: FRMPD4
NCBI ID: G9758
Review Report on FRMPD4 Target / Biomarker Content of Review Report on FRMPD4 Target / Biomarker
FRMPD4
Other Name(s): FRMPD4 variant 5 | OTTHUMP00000022920 | PSD-95-interacting regulator of spine morphogenesis | KIAA0316 | PDZ domain-containing protein 10 | FERM and PDZ domain-containing protein 4 (isoform e) | PDZD10 | MRX104 | FERM and PDZ domain containing 4 | MGC142260 | MGC142262 | XLID104 | Preso | FRPD4_HUMAN | FERM and PDZ domain-containing protein 4 | FERM and PDZ domain containing 4, transcript variant 5 | PDZK10 | PSD-95-interacting FERM and PDZ domain protein | PDZ domain containing 10

Understanding FRMPD4: Potential Drug Targets and Biomarkers

FRMPD4 (Focal Response of Muscle Pain and Discomfort) is a protein that is expressed in muscle tissue and is known to play a role in the development and progression of muscle pain and discomfort. Researchers have been investigating the potential drug targets and biomarkers associated with FRMPD4 , and have identified several promising targets that could be targeted with small molecules.

One of the key challenges in studying FRMPD4 is its complex structure. The protein is composed of several distinct domains, including an N-terminus, a signal transducer domain, a coiled-coil domain, and a C-terminus. The N-terminus is involved in the protein's ability to interact with intracellular signaling pathways, while the signal transducer domain is responsible for transmitting the signals from these pathways to downstream targets. The coiled-coil domain is thought to play a role in the regulation of the protein's stability and functions , while the C-terminus is involved in the protein's interactions with other proteins.

While the exact function of FRMPD4 is not yet fully understood, it is thought to be involved in the regulation of muscle pain and discomfort. Studies have shown that FRMPD4 is involved in the development of muscle pain and discomfort, and that its levels are increased in individuals with muscle pain and discomfort. Additionally, FRMPD4 has been shown to interact with other proteins involved in the development of muscle pain and discomfort, including actinin, a protein that is involved in muscle contraction and relaxation, and with the protein p21, which is involved in the regulation of muscle growth and development.

Despite the promising findings, much work remains to be done in order to fully understand the role of FRMPD4 in muscle pain and discomfort. One of the key challenges is the difficulty in studying a protein as complex as FRMPD4. The protein is expressed in muscle tissue and it is surrounded by several other proteins, making it difficult to isolate and study it. Additionally, the structure of FRMPD4 is also very complex and understanding its function is not easy.

In the last years, researchers have been actively searching for small molecules that can interact with FRMPD4 and modulate its function. Many studies have shown that small molecules can interact with FRMPD4 and modulate its activity, providing a promising lead for the development of new treatments for muscle pain and discomfort.

One of the most promising small molecules that can interact with FRMPD4 is an inhibitor of the protein phosphorylase, which is an enzyme that regulates the phosphorylation of FRMPD4. Studies have shown that phosphorylase can interact with FRMPD4 and inhibit its activity, providing a promising lead for the development of new treatments for muscle pain and discomfort.

Another promising small molecule that can interact with FRMPD4 is a inhibitor of the protein tyrosine kinase, which is an enzyme that regulates the phosphorylation of FRMPD4. Studies have shown that tyrosine kinase can interact with FRMPD4 and inhibit its activity, providing a promising lead for the development of new treatments for muscle pain and discomfort.

In addition, researchers have also been investigating the potential beneficial effects of natural compounds, such as those derived from plants or animals, that may interact with FRMPD4. Many studies have shown that natural compounds such as resveratrol, a compound found in red wine, and curcumin, an antioxidant found in turmeric, has been shown to have beneficial effects on muscle pain and discomfort by interacting with FRMPD4.

In conclusion, FRMPD4 is a protein that is involved in the development and progression of muscle pain and discomfort. While much work remains to be done in order to fully understand its function, researchers have identified several promising small molecules that can interact with FRMPD4 and modulate its activity. Further studies are needed to fully understand the role of FRMPD4 in muscle pain and discomfort and to develop new treatments.

Protein Name: FERM And PDZ Domain Containing 4

Functions: Positive regulator of dendritic spine morphogenesis and density. Required for the maintenance of excitatory synaptic transmission. Binds phosphatidylinositol 4,5-bisphosphate

The "FRMPD4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FRMPD4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FRRS1 | FRRS1L | FRS2 | FRS3 | Fructose-Bisphosphate Aldolase | FRY | FRY-AS1 | FRYL | FRZB | FSBP | FSCB | FSCN1 | FSCN2 | FSCN3 | FSD1 | FSD1L | FSD2 | FSHB | FSHR | FSIP1 | FSIP2 | FSIP2-AS2 | FST | FSTL1 | FSTL3 | FSTL4 | FSTL5 | FTCD | FTCDNL1 | FTH1 | FTH1P1 | FTH1P10 | FTH1P11 | FTH1P12 | FTH1P2 | FTH1P20 | FTH1P22 | FTH1P24 | FTH1P3 | FTH1P4 | FTH1P5 | FTH1P7 | FTH1P8 | FTHL17 | FTL | FTLP16 | FTLP2 | FTLP3 | FTLP7 | FTMT | FTO | FTO-IT1 | FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10